Signification of gene mutational analysis using thyroid biopsy specimens

Signification of gene mutational analysis using thyroid biopsy specimens - Diagnosis and Examination by liquid biopsy for thyroid tumor

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036208

Enrollment

100

Registered

2019-03-15

Start date

2017-12-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with thyroid tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with thyroid tumor Patients with written informed consent

Exclusion criteria

Exclusion criteria: Patients with severe heart disease Patients with severe renal disease Patients with serious mental illness Patients complicated with severe infection Patients with severe diabetes Patients with other malignant tumors Patients with severe dehydration and malnutrition Patients who have other serious complications and are considered difficult to participate Patients who judged inappropriate by an attendant physician

Design outcomes

Primary

Measure	Time frame
Detection rate of genetic abnomalities such as BRAF mutations in blood and thyroid tissue	—

Countries

Japan

Contacts

Public ContactYusuke Ono

Institute of Biomedical Research,Sapporo Higashi Tokushukai Hospital Division of Genome Diagnosis Research

ibr-shth@higashi-tokushukai.or.jp011-722-1110

Outcome results